Ra Pharmaceuticals Company Profile

Ra Pharma™ is developing Cyclomimetics™, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma’s peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches for addressing unmet medical needs. For more information, please visit: www.rapharma.com.

More Information about "Ra Pharmaceuticals" on BioPortfolio

We have published hundreds of Ra Pharmaceuticals news stories on BioPortfolio along with dozens of Ra Pharmaceuticals Clinical Trials and PubMed Articles about Ra Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ra Pharmaceuticals Companies in our database. You can also find out about relevant Ra Pharmaceuticals Drugs and Medications on this site too.